Medical Industry Feature

Maximizing Flu Protection: The Clinical Value of Cell-Based Vaccines


Listen Later

Host: Jennifer Caudle, DO
Guest: Victoria A. Statler, MD, MSc

Test-confirmed influenza outcomes provide a specific measure of influenza vaccine effectiveness (VE) and has helped to illustrate the potential benefit of cell-based versus egg-based vaccines.1 So what data support improved VE from cell-based flu vaccines versus egg-based vaccines? To learn more, join Dr. Jennifer Caudle as she speaks with Dr. Victoria A. Statler, Associate Professor of Pediatrics at the University of Louisville and the Director of the Pediatric Transplant and Immunocompromised Host service at Norton Children’s Hospital.

Reference:

  1. Stein AN, Mills C, McGovern, et al. Superior effectiveness of cell-based versus egg-based quadrivalent influenza vaccines against test-confirmed influenza over three consecutive seasons in the United States. Paper presented at: The Ninth European Scientific Working Group Influenza (ESWI) Influenza Conference; September 17-20, 2023: Valencia, Spain.

USA-FCV-24-0055 08/24

...more
View all episodesView all episodes
Download on the App Store

Medical Industry FeatureBy ReachMD

  • 4
  • 4
  • 4
  • 4
  • 4

4

1 ratings


More shows like Medical Industry Feature

View all
SexMed by ReachMD

SexMed

3 Listeners

Partners in Practice by ReachMD

Partners in Practice

3 Listeners

Second Opinion LIVE! by ReachMD

Second Opinion LIVE!

0 Listeners

Medical Breakthroughs from Penn Medicine by ReachMD

Medical Breakthroughs from Penn Medicine

6 Listeners

Advances in Women's Health by ReachMD

Advances in Women's Health

14 Listeners

GI Insights by ReachMD

GI Insights

18 Listeners

Conference Coverage by ReachMD

Conference Coverage

0 Listeners